GlassScriptPrepare for your visit
Monica Riccomini
Family · Orland, CA · NPI 1750524914
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$740.82
in general payments reported to CMS, 2019-2025 · $203 in 2025
The $203 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Glaxosmithkline, LLC. $195.45
- Merck Sharp & Dohme LLC $173.36
- Sanofi Pasteur INC. $125.60
- Pfizer INC. $67.65
- Biomarin Pharmaceutical INC. $46.85
- Takeda Pharmaceuticals U.S.A., INC. $39.71
Drugs and devices associated with these payments
Vaxelis Gardasil 9 Vaxneuvance Bexsero Beyfortus Rotateq Pediarix Voxzogo 1.2mg Vaqta Menquadfi Penmenvy Enflonsia
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Monica Riccomini listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10593233/monica-riccomini